Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis.

Lidija Ljubicic,Urska Janzic,Mojca Unk,Ana Sophie Terglav,Katja Mohorcic,Fran Seiwerth,Lela Bitar,Sonja Badovinac,Sanja Plestina,Marta Korsic,Suzana Kukulj,Miroslav Samarzija,Marko Jakopovic

Radiology and oncology（2023）

引用 0|浏览5

暂无评分

摘要

The combination of docetaxel and nintedanib can be considered an effective therapy option with an acceptable toxicity profile for patients with advanced NSCLC after the failure of ICI +/- ChT.

查看译文

关键词

lung cancer,nintedanib,efficacy,non-squamous,non-small,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要